Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
The DC Cohort Longitudinal HIV Status Neutral Study
NCT01206920 · View on ClinicalTrials.gov ↗
Study Summary
The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and receiving care in Washington, DC.
Study Locations (14)
District of Columbia
- Kaiser Permanente Mid-Atlantic States — Washington D.C.
- Unity Health Care — Washington D.C.
- Georgetown University — Washington D.C.
- La Clinica Del Pueblo — Washington D.C.
- Whitman-Walker Health — Washington D.C.
- Children's National Medical Center--Pediatric Clinic — Washington D.C.
- Washington Hospital Center — Washington D.C.
- Washington Health Institute — Washington D.C.
- Family and Medical Counseling Service — Washington D.C.
- George Washington Medical Faculty Associates — Washington D.C.
- Howard University Hospital--Adult Clinic — Washington D.C.
- Howard University Hospital--Pediatric Clinic — Washington D.C.
- Veterans Affairs Medical Center — Washington D.C.
- Us Helping Us, People into Living, Inc. — Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,000 participants |
| Start Date | 2011-01 |
| Est. Completion | 2041-01 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01206920
The ClinicalTrials.gov registry entry for NCT01206920 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 19,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 134 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT01206920 reports 14 study locations spanning 1 distinct geographic area — top geographies include District of Columbia. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT01206920 about?
NCT01206920 is a clinical study titled "The DC Cohort Longitudinal HIV Status Neutral Study". The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and...
What is the current status of trial NCT01206920?
This trial is currently recruiting. The enrollment target is 19,000 participants. The study started on 2011-01. Estimated completion is 2041-01.
What conditions does trial NCT01206920 study?
This clinical trial studies the following conditions: HIV, AIDS. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT01206920?
This trial is sponsored by George Washington University, which has 134 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT01206920 being conducted?
This trial has 14 study locations across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.